[1]Shen B, Liu Q,Gu Y,et al.Efficacy and Safety Evalution on Arterial Thrombolysis in Treating Acute Cerebral Infarction[J].Cell Biochem Biophys,2015,73(2):297-304. [2]Leng XY,Chen XY,Chook P,et,al.Correlation of large artery intracranial occlusive disease with carotid intima-media thickness and presence of carotid plaque [J].Stroke.2013;44(1):68-72. [3]Romano FA,Campo-Bustillo JG,Campo I,et al.High-dose atorvastatin enhances impaired cerebral vasomotor reactivity[J].Journal of stroke and cerebrovascular disease,2012,24(6):537. [4]Mogelvang R,Pedersen SH,Flyvbjerg A,et al.Comparison of osteoprotegein to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis[J].Am J Cardiol,2012,109(4):515-520. [5]Doganer Yc,Aydogan U,Aydogdu A,et al.Relatiaonship of cystatin C with coronary artery disease and its severity [J].Coron Artery Dis,2013,24(2)119-126. [6]Lee M,Saver JL,Huang WH,et al.Impact of elevated cystatin level on population amete-analysis[J].Cardiovasc Qual Outcomes,2010,3:675-683. [7]Flynn RWM,MacDonald TM,Murray GD,et al.Persistence,adherence and outcome with antiplatelet regiments following cerebral infarction in the Tayside Stroke Cohort[J].Cerebrovascular dieeases,2012,30(2):519. [8]Roudbary SA,Saadat F,Forghanparast K,et al.Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke [J].Acta Med Iran,2011,49(3):149-152. [9]Youn CS,Choi SP,Kim SH,et al.Serum hightly selective protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke[J].Am J Emerg Med,2012,30:124-128. [10]Lind M,Boman K,Johansson L,et al.D-dimer predicts major bleeding,cardiovascular events and all-cause mortality during warfarin treatment[J].Clin Biochem,2014,47(7/8):570-573.
|